Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro

Vishal M. Balaramnavar; Khurshid Ahmad; Mohd Saeed; Irfan Ahmad; Mehnaz Kamal; Talha Jawaid

doi:10.1039/D0RA90120B

Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M^pro

Vishal M. Balaramnavar,*^a Khurshid Ahmad,^b Mohd Saeed,^c Irfan Ahmad,^de Mehnaz Kamal^f and Talha Jawaid^g

* Corresponding authors

^a Department of Medicinal and Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research, Jaspur Road, Kashipur, India
E-mail: v.balaramnavar@gmail.com

^b Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, South Korea

^c Department of Biology College of Sciences, University of Hail, Saudi Arabia

^d Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia

^e Research Center for Advanced Materials Science, King Khalid University, Abha, Saudi Arabia

^f Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box No. 173, Al-Kharj 11942, Kingdom of Saudi Arabia

^g Department of Pharmacology, College of Medicine, Al Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia

Abstract

Correction for ‘Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M^pro’ by Vishal M. Balaramnavar et al., RSC Adv., 2020, 10, 40264–40275, DOI: 10.1039/D0RA06038K.

Associated articles

Article information

DOI: https://doi.org/10.1039/D0RA90120B
Article type: Correction
Submitted: 10 Nov 2020
Accepted: 10 Nov 2020
First published: 25 Nov 2020
This article is Open Access

Download Citation

RSC Adv., 2020,10, 42765-42765

Permissions

Request permissions

Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M^pro

V. M. Balaramnavar, K. Ahmad, M. Saeed, I. Ahmad, M. Kamal and T. Jawaid, RSC Adv., 2020, 10, 42765 DOI: 10.1039/D0RA90120B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

RSC Advances

Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M^pro

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M^pro

Social activity

Search articles by author

Spotlight

Advertisements